^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ExoDx™ Prostate (IntelliScore) Test

Company:
Bio-Techne
Type:
CE Marked
Related tests:

Details

Evidence
The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the “gray zone”, considering an initial biopsy. The ExoDx Prostate test returns a risk score that determines a patient’s risk of clinically significant prostate cancer (Gleason Score ≥7) on prostate biopsy.
Cancer:
Prostate Cancer
Gene:
ERG (ETS Transcription Factor ERG), PCA3 (Prostate cancer associated 3), SPDEF (SAM Pointed Domain Containing ETS Transcription Factor)
Method:
Liquid biopsy
Approvals
Date
Cancer
Gene
Drug
By
03/22/21
CE
Confirmatory trial(s)